Uterine Cervical Neoplasms: all 1,927 studies

Page 19 of 20. Open to participants first (576), then studies with results posted, then the rest; newest registration first within each.

• Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical CancerCompletedNCT00287911Phase 1
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerCompletedNCT00287885Phase 1
• TRAIL-CC: Trachelectomy, Radical Hysterectomy, and Intimate Life After Cervical Cancer StudyCompletedNCT00278798
• Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3TerminatedNCT00278434Phase 1
• Radiation Therapy in Treating Patients With Cervical CancerCompletedNCT00278304Phase 2
• Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00276796Phase 2
• Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine CervixCompletedNCT00266084
• Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)CompletedNCT00260039Phase 2
• Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.CompletedNCT00258401Not applicable
• Improving Tumor Oxygenation in Cervical CancerWithdrawnNCT00257829Phase 2
• Weekly IV Topotecan and Cisplatin With Radiation in Cervical CarcinomaCompletedNCT00257816Phase 2
• Capecitabine and Docetaxel in Advanced/Recurrent Cervical CancerCompletedNCT00257348Phase 2
• CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of CamptoCompletedNCT00251888Phase 1
• Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance TechniquesCompletedNCT00242034Not applicable
• Screen and Treat for Cervical Cancer PreventionTerminatedNCT00233727Phase 3
• A Comparison of Primary Care and Traditional Internal Medicine ResidentsCompletedNCT00224224
• Folate and Protection Against Cervical CancerTerminatedNCT00220532Phase 1/2
• Pelvic Exenteration in Treating Patients With Recurrent Cervical CancerCompletedNCT00217633Phase 2
• Laparoscopic Sentinel Lymph Node Localization in Operable Cervix CancerCompletedNCT00205010
• Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the CervixTerminatedNCT00204997Not applicable
• Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical CancerStatus unknownNCT00199680Phase 2
• Magnetic Resonance Imaging (MRI) Staging of Cervix CancerCompletedNCT00193934
• High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma CervixCompletedNCT00193830Phase 3
• A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma CervixCompletedNCT00193804
• Concomitant Chemoradiation in Advanced Stage Carcinoma CervixCompletedNCT00193791Not applicable
• Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer CervixCompletedNCT00193752
• Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the CervixStatus unknownNCT00193739Phase 3
• A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical CancerTerminatedNCT00190528Phase 3
• Combidex USPIO - Ultra-small Superparamagnetic Iron OxideCompletedNCT00188695Phase 1/2
• Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)CompletedNCT00188578Phase 1/2
• Cervix: Hypoxia, Interstitial Fluid Pressure and GSH LevelsActive, not recruitingNCT00188539Phase 2
• Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian CancersStatus unknownNCT00178802Phase 2
• Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine CervixCompletedNCT00178269Phase 2
• Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell FunctionStatus unknownNCT00173290
• Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial CarcinomaCompletedNCT00165126
• The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human BeingStatus unknownNCT00155792
• Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)Status unknownNCT00155766Phase 1
• The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer PatientsStatus unknownNCT00155077
• Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical LesionsStatus unknownNCT00154583
• The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human PapillomavirusStatus unknownNCT00154479
• Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the CervixCompletedNCT00152828Phase 1/2
• Usefulness of FDG-PET for Advanced Cervical CancerStatus unknownNCT00146458Phase 3
• Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical CancerWithdrawnNCT00137358Phase 1
• Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsCompletedNCT00127465Phase 1/2
• Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Patients With Cancer of the CervixCompletedNCT00126841
• Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the CervixCompletedNCT00124488
• Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix CancerCompletedNCT00124423
• CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to RadiotherapyCompletedNCT00122772Phase 3
• Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer PatientsStatus unknownNCT00122746Phase 3
• The IMAP Study Improving Management of Mildly Abnormal Pap SmearsStatus unknownNCT00119509Phase 3
• Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWithdrawnNCT00118300Phase 1
• Magnetic Resonance Imaging Guided Gynecologic BrachytherapyCompletedNCT00112307Not applicable
• Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical CancerStatus unknownNCT00108875Phase 1/2
• EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial CancerCompletedNCT00107445Phase 2
• Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal CancerTerminatedNCT00106262Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00098995Phase 1
• Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the CervixCompletedNCT00087113Phase 2
• Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical CancerCompletedNCT00086242Not applicable
• Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap SmearsCompletedNCT00084903Not applicable
• Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the CervixTerminatedNCT00084890Phase 1
• Healing Touch and Relaxation Therapies in Cervical Cancer PatientsCompletedNCT00084123Phase 2
• SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial NeoplasiaCompletedNCT00075569Phase 2
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
• S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
• Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical CancerCompletedNCT00054444Phase 1
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the CervixTerminatedNCT00054067Phase 3
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00054041Phase 2
• Vaginal Changes and Sexual Function in Patients With Cervical CancerCompletedNCT00053261
• Gefitinib in Treating Patients With Cervical CancerCompletedNCT00049556Phase 2
• EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical CancerCompletedNCT00049231Not applicable
• Epoetin Beta in Treating Anemia in Patients With Cervical CancerCompletedNCT00046969Phase 4
• Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?Status unknownNCT00039884Phase 2
• Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical CancerStatus unknownNCT00039338Phase 3
• Comparison of Screening Tests in Detecting Cervical NeoplasiaCompletedNCT00039312Not applicable
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic CancerCompletedNCT00032162Phase 1/2
• Imiquimod in Preventing Cervical Cancer in Women With Cervical NeoplasiaCompletedNCT00031759Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00030472Phase 2
• SU5416 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00026260Phase 2
• Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical CancerCompletedNCT00023660Phase 1/2
• Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerCompletedNCT00019110Phase 1
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00019084Phase 2
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00016926Phase 2
• Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical CancerStatus unknownNCT00008112Phase 2
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the CervixTerminatedNCT00006482Phase 2
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00006224Phase 2
• Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterCompletedNCT00006083Phase 3
• Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00006079Phase 2
• Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNCT00005999Phase 2
• Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the CervixCompletedNCT00005965Phase 2
• Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal CancerCompletedNCT00005941Phase 2
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00005837Phase 2
• Irofulven in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNCT00005070Phase 2
• MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating PatientsCompletedNCT00004936Not applicable
• DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the CervixCompletedNCT00004866Phase 2

← Uterine Cervical Neoplasms overview